The pan-Canadian Pharmaceutical Alliance (PCPA, stylized as pCPA), previously the Pan-Canadian Pricing Alliance and the Generic Value Price Initiative[1] is an alliance between the provinces and territories of Canada to combine their bargaining power to negotiate lower prices on pharmaceutical drugs.
[2][3] Support for inter-provincial coordination on price negotiations for pharmaceuticals began in August 2010 after a meeting of provincial premiers.
[4] The pCPA initially comprised nine provinces and Yukon, with Quebec joining in 2014.
[2] As of 2023, all provinces and territories are members of the Alliance.
[4] The pCPA conducted negotiations for prices on ten drugs in its first three years, including for eculizumab, and estimated it had saved approximately $50,000,000.